Jiangxi Rimag Group Co., Ltd (HKG: 2522), a China-based medical imaging specialist, is planning an initial public offering (IPO) on the Hong Kong Stock Exchange, with details currently being compiled. The company has previously raised a war chest of RMB 900 million through several financing rounds.
Founded in 2014, Rimag is dedicated to establishing and operating medical imaging center networks and exploring service models under China’s tiered diagnosis and treatment system. The company’s business footprint spans 16 provinces, autonomous regions, and municipalities, consisting of 88 imaging centers, including 8 flagship imaging centers, 24 regional shared imaging centers, 43 specialized medical integrated imaging centers, and 13 operational management imaging centers.
In 2022, Rimag generated revenues of RMB 784 million, with an expected market capitalization exceeding HKD 4 billion upon listing.- Flcube.com
